On Jan. 6, 2023, the U.S. Food and Drug Administration (FDA) approved Leqembi (lecanemab-irmb) via the Accelerated Approval…
On Jan. 5, 2023, BioNTech announced that the Company had signed a Memorandum of Understanding with the Government…
On Jan. 5, 2023, the National Institutes of Health, in collaboration with the Administration for Strategic Preparedness and…
On Jan. 5, 2023, National Institutes of Health researchers announded they had published an assessment of 13 studies…
On Jan. 5, 2023, Novavax announced that Spain’s Public Health Commission, Italy’s Ministry of Health, and France’s Haute…
On Jan. 4, 2023, an international research group announced it had for the first time reconstructed ancestors dating…
On Jan. 4, 2023, a National Institutes of Health funded study reported that moderate levels of two outdoor…
On Jan. 1, 2023, a study published in the Lancet reported that concentrations of antibiotic residues found in…
Milestones in Polio illustrates the slow but steady advancements from its clinical description and discovery to widespread infection…
On Dec. 24, 2022, the U.S. Food and Drug Administration (FDA) approved updated labeling for Genentech’s capecitabine tablets…
On Dec. 23, 2022, BioNTech and Fosun Pharmaceutical announced that they had received the certificates of registration as…
On Dec. 22, 2022, Gilead Sciences announced that Sunlenca (lenacapavir), in combination with other antiretroviral(s) (ARV), had been…
On Dec. 22, 2022, resarchers at the National Institutes of Health announced they had used patient stem cells…
On Dec. 21, 2022, Roche announced that the U.S. Food and Drug Administration (FDA) had approved Actemraﾮ (tocilizumab)…
On Dec. 21, 2022, Moderna announced the the finalization of a strategic partnership with the United Kingdom (UK)…
On Dec. 21, 2022, the U.S. Department of Health and Human Services (HHS), through the Administration for Strategic…
On Dec. 20, 2022, the University of Oxford announced study results using data from 7 million people notified…
On Nov. 12, 2022, the World Health Organization (WHO) issued a Disease Outbreak News (DON) on the circulating…
On Dec. 16, 2022, Moderna announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use…
On Dec. 16, 2022, the U.S. Food and Drug Administration approved Ferring Pharmaceuticals’ Adstiladrin (nadofaragene firadenovec-vncg), a non-replicating…
On Dec. 16, 2022, Novavax announced that the Standing Committee on Vaccination (STIKO) in Germany had expanded its…
On Dec. 15, 2022, the University of Oxford Oxfordﾒs Ebola vaccine candidate has been shipped to Uganda, just…
On Dec. 14, 2022, the National Institutes of Health announced that two randomized, placebo-controlled trials evaluating three Ebola…
On Dec. 13, 2022, Texas Biomed announced that it had been designated as a prime contractor by the…
On Dec. 12, 2022, the Oregon Department of Agriculture and the U.S. Department of Agriculture’s Animal Plant Health…
On Dec. 11, 2022, Novavax announced that the Switzerland’s Federal Office of Public Health and Francees Haute Autorite…
On Dec. 10, 2022, CSL announced data affirming the long-term durability and safety of single-infusion HEMGENIX® (etranacogene dezaparvovec-drlb)…
On Dec. 9, 2022, Pfizer and BioNTech announced the companies had received Fast Track Designation from the U.S….
On Dec. 9, 2022, the World Health Organization (WHO) announced that the first doses of one of the…
On Dec. 9, 2022, the U.S. Food and Drug Administration (FDA) approved Genentech’s atezolizumab (Tecentriq) for adult and…